# Ribosomal modifications are associated with mesenchymal fate selection in the neural crest lineage

**Authors:** Irina Poverennaya, Aliia Murtazina, Lei Li, Lorena Maili, Lukas Sourada, Luis Fernando Montano-Gutierrez, Rozalina Galimullina, Tobias Steinschaden, Marketa Kaiser, Tomas Zikmund, Adna Goralija, Teng Gao, Aurore Attina, Ornella Clara, Christoph Bartenhagen, Alek Erickson, Yaakov Gershtein, Shiyuan Chen, Kristyna Polaskova, Jaroslav Sterba, Bettina Semasch, Emma R. Anderson, Varsha Prakash, Theresa Vincent, Maria Arceo, Per Kogner, Susanne Schlisio, Peter V. Kharchenko, Alexandre David, Jozef Kaiser, Matthias Fischer, Jan Skoda, Paul A. Trainor, Andrei S. Chagin, Igor Adameyko

PMC · DOI: 10.1038/s41467-026-70375-6 · 2026-03-09

## TL;DR

This study shows that ribosomal modifications influence the fate of neural crest cells, affecting craniofacial development and neuroblastoma outcomes.

## Contribution

The study identifies specific rRNA modification factors linked to mesenchymal fate in neural crest cells and their role in tumor progression.

## Key findings

- Disruption of rRNA modification factors like NHP2 and TSR3 causes craniofacial malformations.
- High levels of ribosomal control proteins in neuroblastoma correlate with poorer patient survival.
- TSR3 and WDR74 play functional roles in mesenchymal-like tumor states.

## Abstract

Neural crest cells contribute to craniofacial formation by differentiating into skeletogenic mesenchyme and neuro-glial lineages. Using Smart-seq2 single-cell transcriptomics, we show that mesenchymal fate commitment correlates specifically with the expression of rRNA-modifying and ribosome assembly factors, rather than structural ribosomal proteins. Notably, EMG1 and NHP2 introduce key post-transcriptional modifications into 18S rRNA, including m¹acp³ψ at U1248, which requires TSR3 for final maturation. Disrupting NHP2 or TSR3 in vitro and in vivo perturbs cranial neural crest differentiation; post-migratory temporal knockout of Polr1a or Polr1c also causes craniofacial malformations. These findings align with cell type-specific m¹acp³ψ levels during neural crest differentiation. Given the neural crest contribution to neuroblastoma, we analyze patient data to find that elevated ribosomal control and rRNA-modifying proteins predict poorer outcomes. Complementary experiments in neuroblastoma cell lines reveal functional roles for TSR3 and WDR74 in mesenchymal-like tumor states. Together, our results link rRNA modifications and ribosome assembly to fate decisions, suggesting ribosomal heterogeneity shapes both normal development and tumor progression.

Neural crest cells differentiate into skeletogenic mesenchyme and neuro-glial lineages, thereby contributing to craniofacial formation. Here, single-cell analysis of cranial neural crest shows that specific rRNA modification and ribosome assembly factors contribute to skeletogenic fate. Their disruption causes craniofacial defects, while high levels in neuroblastoma predict poor survival.

## Linked entities

- **Genes:** EMG1 (EMG1 N1-specific pseudouridine methyltransferase) [NCBI Gene 10436], NHP2 (NHP2 ribonucleoprotein) [NCBI Gene 55651], TSR3 (TSR3 ribosome maturation factor) [NCBI Gene 115939], POLR1A (RNA polymerase I subunit A) [NCBI Gene 25885], POLR1C (RNA polymerase I and III subunit C) [NCBI Gene 9533], WDR74 (WD repeat domain 74) [NCBI Gene 54663]
- **Diseases:** neuroblastoma (MONDO:0005072)

## Full-text entities

- **Genes:** Shh (sonic hedgehog) [NCBI Gene 20423] {aka 9530036O11Rik, Dsh, HHG-1, Hhg1, Hx, Hxl3}, Prom1 (prominin 1) [NCBI Gene 19126] {aka 4932416E19Rik, AC133, CD133, Prom, Prom-1, Proml1}, Ddx31 (DEAD/H box helicase 31) [NCBI Gene 227674] {aka 5830444G11Rik, Gm997}, Cd1 (CD1 antigen complex) [NCBI Gene 111334], Mcl1 (myeloid cell leukemia sequence 1) [NCBI Gene 17210] {aka Gm52627, Mcl-1}, Myc (Myc proto-oncogene, bHLH transcription factor) [NCBI Gene 17869] {aka Myc2, Niard, Nird, bHLHe39}, Fgf2 (fibroblast growth factor 2) [NCBI Gene 14173] {aka Fgf-2, Fgf2a, Fgfb, bFGF}, Htr3a (5-hydroxytryptamine (serotonin) receptor 3A) [NCBI Gene 15561] {aka 5-HT3, 5-HT3A, 5-HT3R}, Trp53-ps (transformation related protein 53, pseudogene) [NCBI Gene 22060], Ybx1 (Y box protein 1) [NCBI Gene 22608] {aka 1700102N10Rik, EF1A, MSY1, Nsep1, YB-1, dbpB}, Hsp90ab1 (heat shock protein 90 alpha (cytosolic), class B member 1) [NCBI Gene 15516] {aka 90kDa, Hsp84, Hsp84-1, Hsp90, Hspcb}, POLR1A (RNA polymerase I subunit A) [NCBI Gene 25885] {aka A190, AFDCIN, HLD27, RPA1, RPA190, RPA194}, Polr1a (polymerase (RNA) I polypeptide A) [NCBI Gene 20019] {aka 194kDa, 2900087K15Rik, 3010014K16Rik, RPA194, Rpo1-4, mRPA1}, Atrx (ATRX, chromatin remodeler) [NCBI Gene 22589] {aka 4833408C14Rik, ATR2, DXHXS6677E, HP1-BP38, Hp1bp2, Hp1bp38}, Neurog1 (neurogenin 1) [NCBI Gene 18014] {aka AKA, Math4C, Neurod3, bHLHa6, ngn1}, EMG1 (EMG1 N1-specific pseudouridine methyltransferase) [NCBI Gene 10436] {aka C2F, Grcc2f, NEP1}, Mmp2 (matrix metallopeptidase 2) [NCBI Gene 17390] {aka Clg4a, GelA, MMP-2}, POLR1C (RNA polymerase I and III subunit C) [NCBI Gene 9533] {aka AC40, HLD11, RPA39, RPA40, RPA5, RPAC1}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Prdm12 (PR domain containing 12) [NCBI Gene 381359] {aka Gm998}, SNR35 (ncRNA) [NCBI Gene 9164977], Nefm (neurofilament, medium polypeptide) [NCBI Gene 18040] {aka NF-M, NF160, NF165, Nef3, Nfm}, Sox3 (SRY (sex determining region Y)-box 3) [NCBI Gene 20675] {aka Sox-3}, Twist1 (twist basic helix-loop-helix transcription factor 1) [NCBI Gene 22160] {aka M-Twist, Pde, Ska10, Ska<m10Jus>, Twist, bHLHa38}, NHP2 (NHP2 ribonucleoprotein) [NCBI Gene 55651] {aka DKCB2, NHP2P, NOLA2}, HTR3A (5-hydroxytryptamine receptor 3A) [NCBI Gene 3359] {aka 5-HT-3, 5-HT3A, 5-HT3R, 5HT3R, HTR3}, Tert (telomerase reverse transcriptase) [NCBI Gene 21752] {aka EST2, TCS1, TP2, TR, TRT}, MYCN (MYCN proto-oncogene, bHLH transcription factor) [NCBI Gene 4613] {aka FGLDS1, MODED, MPAPA, MYCNsORF, MYCNsPEP, N-myc}, WDR74 (WD repeat domain 74) [NCBI Gene 54663] {aka Nsa1}, Egf (epidermal growth factor) [NCBI Gene 13645], Rrp8 (ribosomal RNA processing 8) [NCBI Gene 101867] {aka 1500003O22Rik, 2900001K19Rik, NML}, Runx2 (runt related transcription factor 2) [NCBI Gene 12393] {aka AML3, CBF-alpha-1, Cbf, Cbfa-1, Cbfa1, LS3}, Ccnd1 (cyclin D1) [NCBI Gene 12443] {aka CycD1, Cyl-1, PRAD1, bcl-1, cD1}, Sox9 (SRY (sex determining region Y)-box 9) [NCBI Gene 20682] {aka 2010306G03Rik, mKIAA4243, mSox9}, Polr1c (polymerase (RNA) I polypeptide C) [NCBI Gene 20016] {aka 40kDa, Polr1e, RPA40, Rpo1-1}, Snai1 (snail family zinc finger 1) [NCBI Gene 20613] {aka Sna, Sna1, Snail, Snail1}, Plp1 (proteolipid protein (myelin) 1) [NCBI Gene 18823] {aka DM20, Plp, jimpy, jp, msd, rsh}, Prrx1 (paired related homeobox 1) [NCBI Gene 18933] {aka A230024N07Rik, K-2, MHox1, Pmx, Pmx1, Prx1}, NHP2 (snoRNA-binding protein NHP2) [NCBI Gene 851319], Mapk3 (mitogen-activated protein kinase 3) [NCBI Gene 26417] {aka Erk-1, Erk1, Ert2, Esrk1, Mnk1, Mtap2k}, Tsr3 (TSR3 20S rRNA accumulation) [NCBI Gene 68327] {aka 0610007P22Rik, 1110014B11Rik}, Sox10 (SRY (sex determining region Y)-box 10) [NCBI Gene 20665] {aka Dom, Sox21, gt}, Cort (cortistatin) [NCBI Gene 12854] {aka CST, PCST}, KMT2A (lysine methyltransferase 2A) [NCBI Gene 4297] {aka ALL-1, ALL1, CXXC7, GAS7, HRX, HTRX}, Tubb3 (tubulin, beta 3 class III) [NCBI Gene 22152] {aka 3200002H15Rik, M(beta)3, M(beta)6}, Nhp2 (NHP2 ribonucleoprotein) [NCBI Gene 52530] {aka 2410130M07Rik, D11Ertd175e, Nola2}, PROM1 (prominin 1) [NCBI Gene 8842] {aka AC133, CD133, CORD12, MCDR2, MSTP061, PROML1}, MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}, Sox2 (SRY (sex determining region Y)-box 2) [NCBI Gene 20674] {aka Sox-2, lcc, ysb}, TSR3 (TSR3 ribosome maturation factor) [NCBI Gene 115939] {aka C16orf42, HsTsr3}, Rpl23 (ribosomal protein L23) [NCBI Gene 65019] {aka 2810009A01Rik}, Wdr74 (WD repeat domain 74) [NCBI Gene 107071] {aka 5730436H21Rik}, RRP8 (25S rRNA (adenine645-N1)-methyltransferase) [NCBI Gene 851656], Wnt1 (wingless-type MMTV integration site family, member 1) [NCBI Gene 22408] {aka Int-1, Wnt-1, sw, swaying}
- **Diseases:** craniofacial ribosomopathies (MESH:D005157), craniofacial syndromes (MESH:C565118), INSS (MESH:D009447), pheochromocytoma (MESH:D010673), dislocation (MESH:D004204), medulloblastoma (MESH:D008527), cervical dislocation (MESH:D002575), glioblastoma (MESH:D005909), overdose (MESH:D062787), congenital disorders (MESH:D009358), GONAD (MESH:D006058), facial anomalies (MESH:C557821), mesenchymal malignant (MESH:C535700), Bowen Conradi syndrome (MESH:C537081), dysmorphic (MESH:D057215), Postoperative pain (MESH:D010149), Cancer (MESH:D009369), Shwachman-Diamond and Treacher Collins syndromes (MESH:D008342), NCC (MESH:C536408), dehydration (MESH:D003681), Schwannoma (MESH:D009442), cytotoxicity (MESH:D064420), micrognathia (MESH:D008844), facial abnormalities (MESH:D063647), congenital craniofacial and cardiac anomalies (MESH:D019465), neuro-glial tumors (MESH:D005910), melanoma (MESH:D008545), metastasis (MESH:D009362), embryonic lethality (MESH:D020964), colon cancer (MESH:D015179), chondrogenesis (MESH:C536017), Pain (MESH:D010146), death (MESH:D003643), Tsr3-deficient (MESH:D007153)
- **Chemicals:** PVDF (MESH:C024865), progesterone (MESH:D011374), Cycloheximide (MESH:D003513), benzyl benzoate (MESH:C006723), isopropanol (MESH:D019840), SDS (MESH:D012967), Buprenorphine (MESH:D002047), PBS (MESH:D007854), Tween-20 (MESH:D011136), ethanol (MESH:D000431), DMSO (MESH:D004121), DAPI (MESH:C007293), citrate (MESH:D019343), PAP (MESH:D010724), CO2 (MESH:D002245), L-glutamine (MESH:D005973), Am (MESH:D000576), water (MESH:D014867), Trizol (MESH:C411644), nucleosides (MESH:D009705), vitamin A (MESH:D014801), agarose (MESH:D012685), chloroform (MESH:D002725), ammonium acetate (MESH:C018824), Polybrene (MESH:D006583), benzyl alcohol (MESH:D019905), nucleotides (MESH:D009711), paraformaldehyde (MESH:C003043), sucrose (MESH:D013395), isoflurane (MESH:D007530), MG-132 (MESH:C072553), Pseudouridine (MESH:D011560), EDTA (MESH:D004492), amino acids (MESH:D000596), MTT (MESH:C070243), N1-methyl pseudouridine (MESH:C013608), F12 (MESH:C007782), corn oil (MESH:D003314), Tamoxifen (MESH:D013629), streptomycin (MESH:D013307), polyacrylamide (MESH:C016679), Triton-X100 (MESH:D017830), MIBG (MESH:D019797), methanol (MESH:D000432), Lipofuscin (MESH:D008062), 3-(3-amino-3-carboxypropyl)uridine (MESH:C006514), 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MESH:C022616), sodium chloride (MESH:D012965), 3-methyluridine (MESH:C008513), sodium deoxycholate (MESH:D003840), OCT (MESH:C051883), 1x (-), hydrogen peroxide (MESH:D006861), paraffin (MESH:D010232), doxycycline (MESH:D004318), penicillin (MESH:D010406), Uridines (MESH:D014529), Fast Green FCF (MESH:C007704), puromycin (MESH:D011691), Blasticidin (MESH:C004500)
- **Species:** Mycoplasma (genus) [taxon 2093], Human gammaherpesvirus 8 (no rank) [taxon 37296], Mus musculus (house mouse, species) [taxon 10090], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Homo sapiens (human, species) [taxon 9606], Danio rerio (leopard danio, species) [taxon 7955], Escherichia coli (E. coli, species) [taxon 562]
- **Mutations:** R26R, T2A, uridine in 1248, C for 2-4
- **Cell lines:** GIMEN — Homo sapiens (Human), Neuroblastoma, Cancer cell line (CVCL_1232), CHLA-15 — Homo sapiens (Human), Neuroblastoma, Cancer cell line (CVCL_6594), tTS — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_V354), STAN NHP2 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_C0R6), CHLA-20 — Homo sapiens (Human), Neuroblastoma, Cancer cell line (CVCL_6602), SH-SY5Y — Homo sapiens (Human), Neuroblastoma, Cancer cell line (CVCL_0019), SBR00022 — Homo sapiens (Human), Transformed cell line (CVCL_H120), rtTA — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_2505), Smart-seq2 — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_A628), STAN — Homo sapiens (Human), Induced pluripotent stem cell (CVCL_EL74), STAN061i-164-1 — Homo sapiens (Human), Induced pluripotent stem cell (CVCL_EM30), SK-N-BE(2) — Homo sapiens (Human), Neuroblastoma, Cancer cell line (CVCL_0528)

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12976135/full.md

---
Source: https://tomesphere.com/paper/PMC12976135